ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NATCOPHARM announcements Natco Pharma Limited announcements and dividends declared NSE

Natco Pharma Limited Complete list of announcements declared & dividend announcements by Natco Pharma Limited NATCOPHARM

Natco Pharma Limited NATCOPHARM listed on NSE and deals in Pharmaceuticals

Announcements and dividends declared by Natco Pharma Limited NATCOPHARM

Natco Pharma's Kothur unit classified as 'voluntary action indicated' by US regulator
Natco Pharma Ltd announced that its Kothur unit in Hyderabad received an Establishment Inspection Report (EIR) from the US FDA, classifying the facility as 'Voluntary Action Indicated' (VAI). The US FDA had previously conducted an inspection of the company
Announcement as on 18 September 2025

Natco Pharma sues Novo Nordisk in generic drug push
The lawyers representing Natco Pharma informed the court that over the past few months it had approached Novo Nordisk to communicate on its non-infringing patents but received no response, said people familiar with the matter. "A clear communication from t
Announcement as on 21 August 2025

Company Announcement
Natco Pharma Limited has informed the Exchange about Transcript
Announcement as on 20 August 2025

Natco Pharma launches generic drug with 180-day exclusivity in US
Natco Pharma has launched Bosentan tablets, a generic version of Tracleer, in the US for treating pulmonary arterial hypertension in young patients. This launch comes with 180-day exclusivity. Lupin Ltd. is Natco's marketing partner for this product. The d
Announcement as on 20 August 2025

NATCOPHARM announced a dividend of Rupees 2 per share, which makes a dividend yield of 0 based on current price. Effective date of this dividend is 19 Tue Aug 2025

Announcement as on 14 August 2025

Announcements by Natco Pharma Limited first page | Next page | Prev page |

NATCOPHARM Natco Pharma Limited current price & indicator signals

Moving Averages for Natco Pharma Limited

  • 5Day Average: 895.45
  • 12Day Average: 908.9
  • 20Day Average: 907.41
  • 50Day Average: 870.6
  • 100Day Average: 861.12
  • 150Day Average: 885.99
  • 200Day Average: 872.59

NATCOPHARM Indicators & signals

Indicator MACD (12,26,9)

902.84, 897.44, 11.04
Indicator MACD is in positive zone

Indicator ADX (14)

2.66, 22.4, 21.24
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 51
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NATCOPHARM Natco Pharma Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
02 Fri Jan 2026 893.05 887.15 to 903.00 0.55% 1.02 times
01 Thu Jan 2026 888.20 884.20 to 901.05 -1.64% 1.24 times
31 Wed Dec 2025 903.05 897.75 to 908.00 0.65% 0.57 times
30 Tue Dec 2025 897.25 887.00 to 907.50 0.17% 0.88 times
29 Mon Dec 2025 895.70 893.45 to 910.00 -1.41% 0.78 times
26 Fri Dec 2025 908.50 906.20 to 920.90 -0.85% 0.64 times
24 Wed Dec 2025 916.25 913.50 to 926.80 -1.16% 0.7 times
23 Tue Dec 2025 927.00 920.00 to 950.90 0.34% 1.35 times
22 Mon Dec 2025 923.85 910.80 to 927.75 0.77% 1.11 times
19 Fri Dec 2025 916.75 913.00 to 943.80 0.21% 1.87 times
18 Thu Dec 2025 914.85 911.05 to 925.00 -0.81% 0.88 times
17 Wed Dec 2025 922.30 913.00 to 930.20 0.09% 1.51 times

Videos related to: NATCOPHARM announcements Natco Pharma Limited announcements and dividends declared NSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

NATCOPHARM announcements Natco Pharma Limited announcements and dividends declared NSE

 

Back to top